| Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis ARYB Lee, SY Wong, LYA Chai, SC Lee, MX Lee, MD Muthiah, SH Tay, ... bmj 376, 2022 | 397 | 2022 |
| Environmental Factors, Toxicants and Systemic Lupus Erythematosus A Mak, SH Tay International Journal of Molecular Sciences 15 (9), 16043-16056, 2014 | 142 | 2014 |
| Endothelial dysfunction in systemic lupus erythematosus–a case-control study and an updated meta-analysis and meta-regression A Mak, NY Kow, H Schwarz, L Gong, SH Tay, LH Ling Scientific reports 7 (1), 7320, 2017 | 69 | 2017 |
| Low‐Density Neutrophils in Systemic Lupus Erythematosus SH Tay, T Celhar, AM Fairhurst Arthritis & Rheumatology 72 (10), 1587-1595, 2020 | 66 | 2020 |
| Clinical utility of circulating anti-N-methyl-d-aspartate receptor subunits NR2A/B antibody for the diagnosis of neuropsychiatric syndromes in systemic lupus erythematosus and … SH Tay, AM Fairhurst, A Mak Autoimmunity reviews 16 (2), 114-122, 2017 | 64 | 2017 |
| Active disease is independently associated with more severe anxiety rather than depressive symptoms in patients with systemic lupus erythematosus SH Tay, PPM Cheung, A Mak Lupus 24 (13), 1392-1399, 2015 | 57 | 2015 |
| A flow cytometry‐based assay for high‐throughput detection and quantification of neutrophil extracellular traps in mixed cell populations O Zharkova, SH Tay, HY Lee, T Shubhita, WY Ong, A Lateef, PA MacAry, ... Cytometry Part A 95 (3), 268-278, 2019 | 56 | 2019 |
| Neutrophil-to-Lymphocyte Ratio Predicts Development of Immune-Related Adverse Events and Outcomes from Immune Checkpoint Blockade: A Case-Control Study PY Lee, KQX Oen, GRS Lim, JL Hartono, M Muthiah, DQ Huang, ... Cancers 13 (6), 1308, 2021 | 47 | 2021 |
| Diagnosing and attributing neuropsychiatric events to systemic lupus erythematosus: time to untie the Gordian knot? SH Tay, A Mak Rheumatology 56 (suppl_1), i14-i23, 2017 | 44 | 2017 |
| Cytokine release syndrome in cancer patients receiving immune checkpoint inhibitors: a case series of 25 patients and review of the literature SH Tay, MMX Toh, YL Thian, BA Vellayappan, AM Fairhurst, YH Chan, ... Frontiers in immunology 13, 807050, 2022 | 42 | 2022 |
| Anti-NR2A/B Antibodies and Other Major Molecular Mechanisms in the Pathogenesis of Cognitive Dysfunction in Systemic Lupus Erythematosus SH Tay, A Mak International Journal of Molecular Sciences 16 (5), 10281-10300, 2015 | 42 | 2015 |
| Cognitive Dysfunction in Systemic Lupus Erythematosus: Immunopathology, Clinical Manifestations, Neuroimaging and Management D Seet, NA Allameen, SH Tay, J Cho, A Mak Rheumatology and Therapy, 1-29, 2021 | 40 | 2021 |
| Bimodal Influence of Vitamin D in Host Response to Systemic Candida Infection—Vitamin D Dose Matters JHJ Lim, S Ravikumar, YM Wang, TP Thamboo, L Ong, J Chen, JG Goh, ... The Journal of infectious diseases 212 (4), 635-644, 2015 | 40 | 2015 |
| 25-Hydroxyvitamin D3 Deficiency Independently Predicts Cognitive Impairment in Patients with Systemic Lupus Erythematosus SH Tay, CS Ho, RCM Ho, A Mak PloS one 10 (12), e0144149, 2015 | 32 | 2015 |
| Elucidating a bidirectional association between rheumatoid arthritis and depression: A systematic review and meta-analysis CYH Ng, SH Tay, RS McIntyre, R Ho, WWS Tam, CSH Ho Journal of affective disorders 311, 407-415, 2022 | 31 | 2022 |
| Impaired IL-23–dependent induction of IFN-γ underlies mycobacterial disease in patients with inherited TYK2 deficiency M Ogishi, AA Arias, R Yang, JE Han, P Zhang, D Rinchai, J Halpern, ... Journal of Experimental Medicine 219 (10), e20220094, 2022 | 30 | 2022 |
| Type I Interferons in Systemic Lupus Erythematosus: A Journey from Bench to Bedside TM Sim, SJ Ong, A Mak, SH Tay International Journal of Molecular Sciences 23 (5), 2505, 2022 | 30 | 2022 |
| A nurse‐led, rheumatologist‐assisted telemedicine intervention for dose escalation of urate‐lowering therapy in gout KF Phang, A Santosa, BPL Low, PSH Tan, ZW Khong, AYN Lim, GG Teng, ... International journal of rheumatic diseases 23 (9), 1136-1144, 2020 | 24 | 2020 |
| Risk factors for immune‐related adverse events from anti‐PD‐1 or anti‐PD‐L1 treatment in an Asian cohort of nonsmall cell lung cancer patients Y Huang, YY Soon, F Aminkeng, SH Tay, Y Ang, ACL Kee, BC Goh, ... International journal of cancer 150 (4), 636-644, 2022 | 23 | 2022 |
| Characterisation of a human antibody that potentially links cytomegalovirus infection with systemic lupus erythematosus JYJ Neo, SYK Wee, I Bonne, SH Tay, M Raida, V Jovanovic, AM Fairhurst, ... Scientific Reports 9 (1), 9998, 2019 | 20 | 2019 |
